Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Cervarix, Cervical Cancer Vaccine by GlaxoSmithKline

Drug (Brand/Generic)

Cervarix

Company/Licensee

GlaxoSmithKline

Therapy Class

Prophylactic vaccine

Target Age Group

Ten years and above

Product Description

Vaccine against HPV types 16 and 18

Current Indication

Prevention of precancerous cervical lesions (high grade cervical intraepithelial neoplasia: CIN grades 2 and 3)

Market Sector

Oncology

Development Status

pproved by the US FDA and Ein 90 countries including the US, EU, Australia and Singapore
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top